As of 2026-10-09, the EV/EBITDA ratio of PureTech Health PLC (PRTC.L) is -0.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTC.L's latest enterprise value is 77.60 mil GBP. PRTC.L's TTM EBITDA according to its financial statements is -137.75 mil GBP. Dividing these 2 quantities gives us the above PRTC.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 19.2x | 13.3x |
| Forward P/E multiples | 10.8x - 15.9x | 13.0x |
| Fair Price | (402.83) - (624.73) | (504.53) |
| Upside | -473.0% - -678.5% | -567.2% |
| Date | EV/EBITDA |
| 2026-10-07 | -0.16 |
| 2026-10-06 | -0.14 |
| 2026-10-05 | -0.12 |
| 2026-10-02 | -0.13 |
| 2026-10-01 | -0.18 |
| 2026-09-30 | -0.25 |
| 2026-09-29 | -0.24 |
| 2026-09-28 | -0.26 |
| 2026-09-25 | -0.26 |
| 2026-09-24 | -0.27 |
| 2026-09-23 | -0.25 |
| 2026-09-22 | -0.22 |
| 2026-09-21 | -0.34 |
| 2026-09-18 | -0.36 |
| 2026-09-17 | -0.39 |
| 2026-09-16 | -0.33 |
| 2026-09-15 | -0.33 |
| 2026-09-14 | -0.32 |
| 2026-09-11 | -0.32 |
| 2026-09-10 | -0.33 |
| 2026-09-09 | -0.33 |
| 2026-09-08 | -0.33 |
| 2026-09-07 | -0.34 |
| 2026-09-04 | -0.35 |
| 2026-09-03 | -0.42 |
| 2026-09-02 | -0.34 |
| 2026-09-01 | -0.33 |
| 2026-08-28 | -0.44 |
| 2026-08-27 | -0.42 |
| 2026-08-26 | -0.33 |
| 2026-08-25 | -0.33 |
| 2026-08-24 | -0.28 |
| 2026-08-21 | -0.27 |
| 2026-08-20 | -0.27 |
| 2026-08-19 | -0.32 |
| 2026-08-18 | -0.25 |
| 2026-08-17 | -0.29 |
| 2026-08-14 | -0.29 |
| 2026-08-13 | -0.38 |
| 2026-08-12 | -0.35 |
| 2026-08-11 | -0.33 |
| 2026-08-10 | -0.30 |
| 2026-08-07 | -0.29 |
| 2026-08-06 | -0.25 |
| 2026-08-05 | -0.27 |
| 2026-08-04 | -0.30 |
| 2026-08-03 | -0.26 |
| 2026-07-31 | -0.31 |
| 2026-07-30 | -0.32 |
| 2026-07-29 | -0.34 |